Crossmark

Most women with breast cancer about to initiate aromatase inhibitors already have bone loss

Published Print: 2021-01

Authors

Gil, R. Hernández San

Rodríguez, E.M. Rodríguez

Rodríguez, L.M. Rodríguez

Delgado, H. Roldán

Jurado, J. Cruz

Pérez, M.J. Sánchez

Prieto, M.J. de la Vega

Vega, L.S. Medina

Rodríguez-Bethencourt, M.A. Gómez

Rodríguez, J. Oramas

Álvarez, B.E. Alonso

López, J.N. Batista
License Information

Text and Data Mining valid from 2021-01-01

Version of Record valid from 2020-09-01
More Information

This article is maintained by: Elsevier

Article Title: Most women with breast cancer about to initiate aromatase inhibitors already have bone loss

Journal Title: Medicina Clínica Práctica

CrossRef DOI link to publisher maintained version: https://doi.org/10.1016/j.mcpsp.2020.100156

Content Type: article

Copyright: © 2020 The Authors. Published by Elsevier España, S.L.U.

Document is current